Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo
- PMID: 9240964
- DOI: 10.1096/fasebj.11.8.9240964
Adenoviral/retroviral vector chimeras: a novel strategy to achieve high-efficiency stable transduction in vivo
Abstract
Gene therapy to correct defective genes requires efficient gene delivery and long-term gene expression. Realization of both goals with available vector systems has so far not been achieved. As a novel approach to solve this problem, we have developed a chimeric viral vector system that exploits favorable aspects of both adenoviral and retroviral vectors. In this schema, adenoviral vectors induce target cells to function as transient retroviral producer cells in vivo. The progeny retroviral vector particles can then effectively achieve stable transduction of neighboring cells. In this system, the nonintegrative adenoviral vector is rendered functionally integrative via the intermediate generation of an induced retroviral producer cell. Such chimeric vectors may now allow realization of the requisite goals for specific gene therapy applications.
Similar articles
-
Stable in vivo gene transduction via a novel adenoviral/retroviral chimeric vector.Nat Biotechnol. 1997 Sep;15(9):866-70. doi: 10.1038/nbt0997-866. Nat Biotechnol. 1997. PMID: 9306401
-
Vaccinia viral/retroviral chimeric vectors.Curr Gene Ther. 2004 Dec;4(4):417-26. doi: 10.2174/1566523043346101. Curr Gene Ther. 2004. PMID: 15578991 Review.
-
Emerging adenoviral vectors for stable correction of genetic disorders.Curr Gene Ther. 2007 Aug;7(4):272-83. doi: 10.2174/156652307781369074. Curr Gene Ther. 2007. PMID: 17969560 Review.
-
Transgene amplification and persistence after delivery of retroviral vector and packaging functions with E1/E4-deleted adenoviruses.Cancer Gene Ther. 2000 Aug;7(8):1135-44. doi: 10.1038/sj.cgt.7700212. Cancer Gene Ther. 2000. PMID: 10975674
-
Functional characterization of adenoviral/retroviral chimeric vectors and their use for efficient screening of retroviral producer cell lines.Hum Gene Ther. 1999 Jan 20;10(2):189-200. doi: 10.1089/10430349950018986. Hum Gene Ther. 1999. PMID: 10022544
Cited by
-
Viral vectors for gene transfer: a review of their use in the treatment of human diseases.Drugs. 2000 Aug;60(2):249-71. doi: 10.2165/00003495-200060020-00002. Drugs. 2000. PMID: 10983732 Review.
-
Adenovirus vectors in hematopoietic stem cell genome editing.FEBS Lett. 2019 Dec;593(24):3623-3648. doi: 10.1002/1873-3468.13668. Epub 2019 Nov 20. FEBS Lett. 2019. PMID: 31705806 Free PMC article. Review.
-
Genetically Engineered-Cell-Membrane Nanovesicles for Cancer Immunotherapy.Adv Sci (Weinh). 2023 Sep;10(26):e2302131. doi: 10.1002/advs.202302131. Epub 2023 Jul 6. Adv Sci (Weinh). 2023. PMID: 37409429 Free PMC article. Review.
-
Efficient c-kit receptor-targeted gene transfer to primary human CD34-selected hematopoietic stem cells.J Virol. 2001 Nov;75(21):10393-400. doi: 10.1128/JVI.75.21.10393-10400.2001. J Virol. 2001. PMID: 11581407 Free PMC article.
-
A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.PLoS One. 2013 Oct 9;8(10):e75574. doi: 10.1371/journal.pone.0075574. eCollection 2013. PLoS One. 2013. PMID: 24130722 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials